Receptor-specific ligands distinguish natriuretic peptide receptors-A and -C in primate tissues

Molecular and Cellular Biochemistry

Volumn 178, Issue 1-2, 1998, Pages 317-324

  Sehl, Patricia ^a   Tom, Jeff Y K ^a   Oare, David ^a   Lowe, David G ^a  

^a GENENTECH INC   (United States)

Author keywords

Atrial natriuretic peptide; Membrane guanylyl cyclase; Natriuretic peptide receptor; Neutral endopeptidase

Indexed keywords

ATRIAL NATRIURETIC FACTOR RECEPTOR; LIGAND; MEMBRANE METALLOENDOPEPTIDASE; NATRIURETIC FACTOR;

ANIMAL TISSUE; ARTICLE; HUMAN; HUMAN CELL; KIDNEY; LUNG; MALE; NONHUMAN; RHESUS MONKEY;

AMINO ACID SEQUENCE; ANIMALS; ATRIAL NATRIURETIC FACTOR; BINDING, COMPETITIVE; CELL LINE; GUANYLATE CYCLASE; HUMANS; KIDNEY; LIGANDS; MACACA MULATTA; MEMBRANES; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SPECIES SPECIFICITY;

EID: 0031911816     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006823732336     Document Type: Article

References (30)

1. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML: Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70: 665-699, 1990
2. Ruskoaho H: Atrial natriuretic peptide: Synthesis, release, and metabolism. Pharmacol Rev 44: 479-602, 1993
3. Chinkers M, Garbers DL, Chang M-S, Lowe DG, Chin H, Goeddel DV, Schulz S: A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338: 78-83, 1989
4. Lowe DG, Chang MS, Hellmiss R, Chen E, Singh S, Garbers DL, Goeddel DV: Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. EMBO J 8: 1377-1384, 1989
5. Chang MS, Lowe DO, Lewis M, Hellmiss R, Chen E, Goeddel DV: Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 341: 68-72, 1989
6. Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, Garbers DL: The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 59: 1155-1162, 1989
7. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV: Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252: 120-123, 1991
8. Wilcox JN, Augustine A, Goeddel DV, Lowe DG: Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol Cell Biol 11: 3454-3462, 1991
9. Anand-Srivastava MB, Trachte GJ: Atrial natriuretic factor receptors and signal transduction mechanisms. Pharm Rev: 455-497, 1993
10. Almeida FA, Suzuki M, Scarborough RM, Lewicki JA, Maack T: Clearance function of type C receptors of atrial natriuretic factor in rats. Am J Physiol 256: R469-R475, 1989
11. Okolicany J, McEnroe GA, Koh GY, Lewicki JA, Maack T: Clearance receptor and neutral endopeptidase-mediated metabolism of atrial natriuretic factor. Am J Physiol 263: F546-F553, 1992
12. Koehn JA, Norman JA, Jones BN, LeSueur L, Sakane Y, Ghai RD: Degradation of Atrial Natriuretic Factor of Kidney Cortex Membranes. J Biol Chem 262: 11623-11627, 1987
13. Maack T, Suzuki M, Almeida FA, Nussenzveig D, Scarborough RM, McEnroe JA, Lewicki JA: Physiological role of silent receptors of atrial natriuretic factor. Science 238: 675-678, 1987
14. Nussenzveig DR, Lewicki JA, Maack T: Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor. J Biol Chem 265: 20952-20958, 1990
15. Fuller F, Porter JG, Arfsten AE, Miller J, Schilling JW, Scarborough RM, Lewicki JA, Schenck DB: Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. J Biol Chem 263: 9395-9401, 1988
16. Li C, Booze RM, Hersh LB: Tissue-specific expression of rat neutral endopeptidase (neprilysin) mRNAs. J Biol Chem 270: 5723-5728, 1995
17. Wilkins MR, Settle SL, Kirk JE, Taylor SA, Moore KP, Unwin RJ: Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat. Br J Pharmacol 107: 50-57, 1992
18. Jin H, Li B, Cunningham B, Tom J, Yang R, Sehl P, Thomas GR, Ko A, Oare D, Lowe DG: Novel analog of atrial natriuretic peptide selective for receptor-A produces increased diuresis and natriuresis in rats. J Clin Invest 98: 969-976, 1996
19. Cunningham BC, Lowe DG, Li B, Bennett BD, Wells JA: Production of an atrial natriuretic peptide variant that is specific for type A receptors. EMBO J 13: 2508-2515, 1994
20. Schoenfeld JR, Sehl P, Quan C, Burnier JP, Lowe DG: Agonist selectivity for three species of natriuretic peptide receptor-A. Mol Pharm 47: 172-180, 1995
21. Weis J: Different inhibitory potencies of various ANF-analogues in the isolated aorta from four rodent species. Pharm and Tox 68: 282-283, 1991
22. Lowe DG, Fendly BM: Human natriuretic peptide receptor-A guanylyl cyclase. Hormone cross-linking and antibody reactivity distinguish receptor glycoforms. J Biol Chem 267: 21691-21697 1992
23. Drewett JG, Fendly BM, Garbers DL, Lowe DG: Natriuretic peptide receptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of precontracted rat aorta. J Biol Chem 270: 4668-4674, 1995
24. Kenny AJ, Bourne A, Ingram J: Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem J 291: 83-88, 1993
25. Olson LJ, Lowe DG, Drewett JG: Novel natriuretic peptide receptor/guanylyl cyclase A- selective agonist inhibits angiotensin II- and forskolin-evoked aldosterone synthesis in a human zone glomerulosa cell-line. Mol Pharmacol 50: 430-435, 1996
26. Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann W-G: Isolation and structural analysis of 'urodilatin', a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr 66: 752-759, 1988
27. Heim J-M, Singh S, Fulle H-J, Gerzer R: Comparison of a cloned ANF-sensitive guanylate cyclase (GC-A) with particulate guanylate cyclase from adrenal cortex. Arch Pharm 345: 64-70, 1992
28. Féthière J, De Léan A: Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype. Mol Pharm 40: 913-922, 1991
29. Blaine EH, Heinel LA, Schorn TW, Marsh EA, Whinnery MA: The character of the atrial natriuretic response: Pressure and volume effects. J Hyperten 4: S17-S24, 1986
30. Bestle MH, Bie P: Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs. Acta Physiol Scand 149: 77-83, 1993